Skip to content

The Clinical Characteristic, Coronary Artery Lesions, Spasmic Artery and Treatment Strategy in Variant Angina Pectoris Patients

The Clinical Characteristic, Coronary Artery Lesions, Spasmic Artery and Treatment Strategy in Variant Angina Pectoris Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018394
Enrollment
Unknown
Registered
2018-09-15
Start date
2018-09-15
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

variant angina pectoris

Interventions

Case series:no intervention

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. When angina onset, electrocardiogram (ECG) or dynamic electrocardiogram (Holter) recorded ST segment significantly raised (1 mm or higher) and/or high T wave (including pseudo normalization of T wave) in two or more of the associated leads. The elevated ST segment and/or high T wave back to the state before the onset of angina pectoris when angina pectoris relieved. VAP will be diagnosed if ST-elevation changes in acute myocardial infarction (STEMI) and other non-coronary lesions are excluded. 2. Informed consent has been signed by the patient or his or her legal guardian. 3. Willing and able to receive 3 years follow-up.

Exclusion criteria

Exclusion criteria: 1. Acute ST-segment elevation myocardial infarction (STEMI); 2. Acute pericarditis; 3. Early repolarization syndrome with chest pain; 4. Hyperkalemia with chest pain; 5. Anxiety with ST elevation; 6. Non-cardiac chest pain accompanied by ST elevation.

Design outcomes

Primary

MeasureTime frame
clinical characteristic;coronary lesions;target vessel site of spasm in VAP patients;arrhythmia;treatment;

Secondary

MeasureTime frame
high-density lipoprotein cholesterol;low-density lipoprotein cholesterol;triglyceride;total cholesterol;alanine aminotransferase;aspartate Aminotransferase;Hemoglobin A1c;Homocysteine;serum creatinine;Serum cystatin C;blood uric acid;urine microalbumin;C-reactive protein;

Countries

China

Contacts

Public ContactShen Yuxiang

He'nan Provincial People's Hospital

syxchn@163.com+86 13598826288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026